Search results
The privileged status of orphan medicines in Germany
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoIn Germany, new measures have come into effect as part of the GKV-FinStG Act in 2022 that put into question this market’s desirability for orphan drug...
Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up
Zacks via Yahoo Finance· 5 months agoArcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted the Orphan Drug...
Can Axsome Hold Out Till Depression Drug Becomes a Blockbuster?
Motley Fool· 1 year agoAxsome Therapeutics' (NASDAQ: AXSM) psychiatric drug Auvelity could reach blockbuster status by the...
FDA fast track status granted to iECURE neonatal OTC deficiency treatment
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has granted fast track designation for iECURE’s gene...
PTC Stock Has Gained 41% This Week Alone, And It's Still Sprinting
Investor's Business Daily· 2 years agoShares of PTC stock on Thursday continued a seven-day run —including a 41% sprint this week — on...
Why Is Penny Stock Soligenix Trading Higher On Monday?
Benzinga via Yahoo Finance· 3 weeks agoOn Monday, Soligenix Inc (NASDAQ:SNGX) received an FDA orphan drug designation for the active...
Roche's (RHHBY) Evrysdi Gets FDA Nod for Label Extension
Zacks via Yahoo Finance· 2 years agoRoche RHHBY announced that the FDA approved a label extension of its spinal muscular atrophy (SMA)...
Analysis-Prices for new US drugs rose 35% in 2023, more than the previous year
Reuters via Yahoo News· 3 months agoPharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022,...
KalVista Pharmaceuticals Inc (KALV) Reports Second Fiscal Quarter Results
GuruFocus.com via Yahoo Finance· 5 months agoKalVista Pharmaceuticals Inc (NASDAQ:KALV) targets NDA filing for sebetralstat in H1 2024 following...
What's Going On With Cadrenal Therapeutics Stock Today
Benzinga via Yahoo Finance· 1 year agoThe FDA has granted a Fast Track designation to Cadrenal Therapeutics Inc's (NASDAQ: CVKD)...